04/16/2024
3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/11/2024
7:31 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:32 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:33 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:33 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:52 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:38 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:45 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:58 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:58 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:58 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:44 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:36 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:27 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:04 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:41 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:57 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:59 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
7:00 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
7:00 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:22 PM | Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:46 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:46 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:33 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:22 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
AI “wealth window” is closing soon! (Ad) Today, I’m making my boldest prediction ever.
Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… |
02/22/2024
6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/09/2024
11:40 AM | Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024
5:02 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:07 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:13 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:47 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:39 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:41 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
6:47 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
4:08 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
5:02 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:45 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
6:54 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:43 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:46 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:38 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
10:15 AM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:52 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
4:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
3:15 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
12:06 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
7:01 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
7:01 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:29 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
4:30 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
7:40 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:13 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:13 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:18 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
3:40 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
5:05 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
5:09 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:44 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023
4:47 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:13 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023
5:07 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023
5:07 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023
5:08 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4/A | |
07/05/2023
3:30 PM | Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:30 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:11 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:11 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:12 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:12 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:28 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
AI “wealth window” is closing soon! (Ad) Today, I’m making my boldest prediction ever.
Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… |
05/04/2023
6:45 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2023
5:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
